Development and application of the direct mycobacterial growth inhibition assay: a systematic review

Introduction: First described by Wallis et al. in 2001 for the assessment of TB drugs, the direct mycobacterial growth inhibition assay (MGIA) offers a tractable ex vivo tool measuring the combined influences of ho...

Description complète

Détails bibliographiques
Auteurs principaux:	Painter, H, Harriss, E, Fletcher, H, McShane, H, Tanner, R
Format:	Journal article
Langue:	English
Publié:	Frontiers Media 2024

Documents similaires

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
par: Hannah Painter, et autres
Publié: (2024-02-01)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
par: Tanner, R, et autres
Publié: (2021)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
par: Pepponi, I, et autres
Publié: (2017)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
par: Mcshane, H, et autres
Publié: (2017)

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
par: Brennan, M, et autres
Publié: (2017)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
par: Tanner, R, et autres
Publié: (2017)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
par: Painter, H, et autres
Publié: (2020)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
par: Tanner, R, et autres
Publié: (2011)

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
par: Tanner, R, et autres
Publié: (2019)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
par: Hannah Painter, et autres
Publié: (2020-02-01)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
par: Painter, H, et autres
Publié: (2024)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
par: Marsay, L, et autres
Publié: (2013)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
par: McShane, H, et autres
Publié: (2016)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
par: O'Shea, M, et autres
Publié: (2018)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
par: Tanner, R, et autres
Publié: (2020)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
par: Tanner, R, et autres
Publié: (2021)

Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
par: Tanner, R
Publié: (2015)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
par: Marsay, L, et autres
Publié: (2013)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
par: O'Shea, M, et autres
Publié: (2018)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
par: Rachel Tanner, et autres
Publié: (2020-01-01)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
par: Matthew K. O’Shea, et autres
Publié: (2018-09-01)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
par: Fletcher, H, et autres
Publié: (2013)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
par: Ongarj, J, et autres
Publié: (2024)

Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes
par: Naranbhai, V, et autres
Publié: (2015)

Association of human antibodies to arabinomannan with enhanced mycobacterial opsonophagocytosis and intracellular growth reduction
par: McShane, H, et autres
Publié: (2016)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 1; peer review: 2 approved]
par: Rachel Tanner, et autres
Publié: (2021-03-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
par: Rachel Tanner, et autres
Publié: (2021-09-01)

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection
par: Matthew K. O'Shea, et autres
Publié: (2018-12-01)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
par: McNeill, E, et autres
Publié: (2018)

RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice
par: Satria A. Prabowo, et autres
Publié: (2019-04-01)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
par: Matsumiya, M, et autres
Publié: (2014)

A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity
par: Emil Joseph Vergara, et autres
Publié: (2024-07-01)

Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
par: Christina Jensen, et autres
Publié: (2017-06-01)

Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
par: Vivek Naranbhai, et autres
Publié: (2015-11-01)

Author Correction: Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
par: Christina Jensen, et autres
Publié: (2024-03-01)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
par: Tanner, R, et autres
Publié: (2016)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
par: Eileen McNeill, et autres
Publié: (2018-12-01)

Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.
par: Richard Baguma, et autres
Publié: (2017-01-01)

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
par: Hyejon Lee, et autres
Publié: (2019-04-01)

Whole Blood Mycobacterial Growth Assays for Assessing Human Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis
par: Jeroen Bok, et autres
Publié: (2021-05-01)